Table 2 Site-specific event rates of outcomes at 1 year
Median (Q1, Q3) 1-year event ratea, % | |
|---|---|
Death or lung transplant | 9.8 (6.3, 17.5) |
Hospitalization | 21.3 (12.5, 30.8) |
Decline in FVC ≥ 10% (mL) or death or lung transplant | 32.0 (21.4, 37.5) |
Decline in FVC ≥ 10% predicted or death or lung transplant | 21.4 (13.9, 28.5) |
Decline in DLco ≥ 15% (mmol/min/kPa) or death or lung transplant | 35.1 (26.7, 45.7) |
Decline in DLco ≥ 15% predicted or death or lung transplant | 15.1 (11.1, 25.0) |
Increase in SGRQ total score ≥ 7 or death or lung transplant | 35.3 (29.8, 43.6) |
Increase in SGRQ activity score ≥ 5 or death or lung transplant | 48.6 (39.2, 57.5) |
Increase in SGRQ impact score ≥ 7 or death or lung transplant | 34.8 (30.6, 43.5) |
Increase in SGRQ symptoms score ≥ 8 or death or lung transplant | 35.7 (25.8, 42.5) |
Decrease in CASA-Q cough impact domain ≥ 11 or death or lung transplant | 32.3 (26.3, 39.7) |
Decrease in CASA-Q cough symptoms domain ≥ 11 or death or lung transplant | 31.4 (25.9, 36.3) |
Decrease in EuroQoL-5D index score ≥ 0.06 or death or lung transplant | 37.7 (28.6, 43.8) |
Decrease in EuroQoL-5D VAS score ≥ 8 or death or lung transplant | 38.7 (29.5, 45.8) |
Decrease in SF-12 MCS score ≥ 6 or death or lung transplant | 28.7 (24.0, 33.5) |
Decrease in SF-12 PCS score ≥ 5 or death or lung transplant | 33.5 (30.3, 40.2) |